Keyword: PET imaging

This page displays contents related to the keyword.

Promising Results from First-in-Humans Study of a Novel PET Radiopharmaceutical - Study Continues with Rheumatoid Arthritis Patients

16.04.2021

The preliminary trial results of a novel radiopharmaceutical for PET imaging of inflammation developed at the University of Turku, Finland, have been published. The compound, which targets the vascular adhesion protein 1 (VAP-1) that regulates inflammatory cell traffic, is the first radiopharmaceutical that has been developed completely in Finland and has advanced to clinical trials. In the study that started with healthy volunteers, the radiopharmaceutical was found to be well tolerated and safe.